Benzinga - Tue, 04 May 2021 08:08:07 -0400
Benzinga - Wed, 28 Apr 2021 08:20:08 -0400
Benzinga - Mon, 19 Apr 2021 16:45:13 -0400
Benzinga - Tue, 13 Apr 2021 07:02:23 -0400
Benzinga - Mon, 12 Apr 2021 12:00:14 -0400
Benzinga - Mon, 12 Apr 2021 10:27:41 -0400
Benzinga - Fri, 05 Mar 2021 09:13:03 -0400
Benzinga - Thu, 04 Mar 2021 17:41:04 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. The firm earns majority of its revenues from United Kingdom. It operates mainly in United States and United Kingdom.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-28
REV
Q4 2020Est.ActualSurprise
EPS-0.010
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AKTXAkari Therapeutics-2.69%69.6M

Akari Therapeutics Company Questions & Answers

Q

How do I buy Akari Therapeutics (AKTX) stock?

A

You can purchase shares of Akari Therapeutics (NASDAQ: AKTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Akari Therapeutics's (AKTX) main competitors?

A

Other companies in Akari Therapeutics’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Teligent (NASDAQ:TLGT) and Cumberland (NASDAQ:CPIX).

Q

What is the target price for Akari Therapeutics?

A

The latest price target for Akari Therapeutics (NASDAQ: AKTX) was reported by B. Riley FBR on 2020-03-13. The analyst firm set a price target for 5.00 expecting AKTX to rise to within 12 months (a possible 176.24% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is Akari Therapeutics (AKTX) stock ?

A

The stock price for Akari Therapeutics (NASDAQ: AKTX) is $1.81 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Akari Therapeutics (AKTX) dividend?

A

There are no upcoming dividends for Akari Therapeutics.

Q

When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?

A
Akari Therapeutics’s Q1 earnings are confirmed after-market from now on May 28, 2021.
Q

When is the upcoming split for AKTX?

A

There is no upcoming split for Akari Therapeutics.